Sustained Release of Hydrogen Sulfide (H<sub>2</sub>S) from Poly(Lactic Acid) Functionalized 4-Hydroxythiobenzamide Microparticles to Protect Against Oxidative Damage.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 31139973.
- Also identified by DOI 10.1007/s10439-019-02270-9 and PMC identifier 6650332.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Hydrogen sulfide (H<sub>2</sub>S) has emerged as a gaseous mediator capable of exhibiting many beneficial properties including cytoprotection, anti-inflammation, and vasodilation. The study presented here provides characterization of a poly(lactic acid) polymer with a functionalized 4-hydroxythiobenzamide (PLA-4HTB) capable of extended H<sub>2</sub>S release. The polymer was used to fabricate microparticles that can be potentially loaded with a drug allowing for co-release of the drug and H<sub>2</sub>S. Microparticles with the average diameter of 500 ± 207 nm were fabricated and shown to release 77.0 ± 1.76 µM of H<sub>2</sub>S over 4 weeks (release of H<sub>2</sub>S from 1 mg of particles). To test for the antioxidant properties of the PLA-4HTB microparticles, human embryonic kidney 293 cells were first incubated with PLA-4HTB microparticles and then oxidative stress was induced using CoCl<sub>2</sub>. Particle suspensions of 1 mg/mL were shown to protect cells resulting in reactive oxygen species (ROS) levels of superoxide that were similar to that of the control group. The microparticles fabricated from the PLA-4HTB released H<sub>2</sub>S over a sustained period of weeks to months, while providing protection from ROS. The microparticles described in this article represent a new platform technology that could be used to prevent and treat diseases caused by oxidative damage.
Medical subject headings
- Benzamides
- Drug Carriers
- Hydrogen Sulfide
- Oxidative Stress
- Polyesters